Gesundheit medical travel
STUDY TOUR FOR
PROSTATE CANCER SPECIALISTS
A unique opportunity for professional development
Study Tours are organised trips for senior healthcare professionals from Finland, Norway, Sweden and Denmark.
These tours offer a unique opportunity to meet and learn from the world’s leading professionals, together with peers from across the Nordics.
15+ RENOWNED SPEAKERS
Meet the specialists from San Raffaele Hospital in an informal setting.
JANUARY 15 - 16 2026
The full package includes travel, accomodation and academic program.
Study Tour for Prostate Cancer Specialists
Topics: Advances in localised, locally advanced and metastatic prostate cancer
Destination: San Raffaele Hospital, Milan, Italy
A packed 2-day program with the world-renowned team of oncologists and urologists from San Raffaele Hospital, Milan sharing best practices and recent research.
Do you wish to hear about other Study Tours: Send an email to contact@gesundheittravel.com
Early Bird Price before July 1st:
Get a discount if you book your seat before July 1st.
San Raffaele Hospital, Milan
Our next excursion
The San Raffaele Hospital is one of Italy’s leading research centre in the field of prostate cancer, with a strong reputation for its innovative research and clinical expertise. The centre is home to a team of world-renowned experts who are dedicated to improving the diagnosis, treatment, and prevention of prostate cancer.
Professor Alberto Briganti
Professor Alberto Briganti is a Full Professor of Urology at Vita-Salute University San Raffaele, Milan, and Deputy Director of the Urological Research Institute. He leads the Prostate Cancer Clinical and Research Program and oversees the Robotic Urology Program. After earning his MD in 2002, he completed a uro-oncological fellowship in Montreal and obtained a Ph.D. in 2016. Briganti is Editor-in-Chief of European Urology and an active member of key European urology organizations. A recipient of the 2016 EAU Crystal Matula Award, he has published over 1,500 peer-reviewed papers, with a primary focus on urological oncology.
Professor Francesco Montorsi
Professor Francesco Montorsi is a Professor and Chairman of Urology at Vita-Salute San Raffaele University in Milan. A highly cited researcher with an H-Index of 155, he has authored over 1,881 peer-reviewed articles, focusing on urological malignancies, sexual dysfunction, and benign prostatic hyperplasia. He has published in top journals like NEJM, The Lancet, and European Urology, where he was Editor-in-Chief (2006-2013). He has held key leadership roles in EAU and San Raffaele Hospital and received numerous prestigious awards, including the Matula Award (1998) , Hugh Hampton Young Award (2018), and Frans Debruyne Lifetime Achievement Award (2019).
Professors Alberto Briganti and Francesco Montorsi has designed the agenda together with our Nordic faculty.
Our faculty
Our faculty, made up of leading experts in their fields, has developed the curriculum for this Study Tour.
Passionate about sharing their knowledge, the faculty is committed to ensuring the tour is informative and engaging, and that it provides prostate cancer specialists with the knowledge they need to provide the best possible care for their patients.
Anders Bjartell, MD, PhD, FEBU
Professor of Urology, Dept of Translational Medicine, Medical Faculty, Lund University
Senior Consultant, Dept of Urology, Skåne University Hospital
Professor Bjartell has been national principal investigator for several trials of new drugs in metastatic prostate cancer and head of the clinical trial unit at the Urology Department at Skåne University Hospital in Malmö. He leads a research group in translational prostate cancer research with long-term experience in prostate cancer biomarkers. He has participated in several EU-sponsored prostate cancer projects and has published more than 420 peer‑reviewed articles (Pubmed) and 541 in Web-of-Science with an H-index of 70.
He was appointed Associate Professor at Lund University in 1995, became Specialist in Urology in 1998, and received his Fellows of the European Board of Urology (FEBU) diploma in 1999. In 2006, Professor Bjartell became full Professor in Clinical Urology, and Senior Consultant at Skåne University Hospital in Malmö. He has received the EAU Frans Debruyne LifeTime Achievement Award, the Dominique Chopin Distinguished Award and the BJUI Blandy Prize.
Antti Rannikko, MD, PhD, FEBU
Chief of Department at HUS Helsinki University Hospital, Department of Urology and Professor of Urology at the University of Helsinki, Finland
Antti Rannikko’s research group focuses on many aspects of prostate cancer from screening to diagnosis, and treatment of local and advanced prostate cancer to cancer follow-up. Research methods range from large, randomized trials and retrospective registry studies to translational studies and n-of-1 studies. He has published approximately 150 peer reviewed articles, supervised six PhD theses, is currently supervising 15 PhD theses, has H-index of 40 and has 9300 citations (Google Scholar). Research group web page: www.hucc.fi.
Professor Rannikko received his PhD in 1997 in molecular biology studies on reproductive endocrinology, completed residency in general surgery in 2003 and in urology in 2005. He holds the titles of docent (adjunct professor) of experimental urology (2006) and clinical urology (2012).
Jan Oldenburg, MD, PhD
Professor at the Medical Faculty of the University of Oslo and Senior Consultant at the Department of Oncology, Akershus University Hospital (Ahus)
Professor Oldenburg is a member of prostate cancer panel of the EAU (European Association of Urology), the European Society of Oncology (ESMO) testicular panel and the Norwegian guidelines group for prostate cancer.
He is also head of the Norwegian Prostate Cancer Consortium (NPCC). Oldenburg is the National Coordinator of the ProBio study – an international, multi-centre, outcome-adaptive, multi-arm, multiple assignment, randomised controlled, biomarker-driven, platform trial in men with de novo metastatic hormone-sensitive (mHSPC) or metastatic castration-resistant (mCRPC) prostate cancer (Probiotrial.org) He has > 100 peer-reviewed publication in the field of uro-oncology, which were cited > 7500 times, resulting in a H index of 41 on Google scholar.
Michael Borre, Dr.Med, PhD
Senior consultant and Professor at Department of Urology, Aarhus University Hospital at Aarhus University, Denmark
Professor Borre’s two academic theses (PhD & DMSci) focused on prostate cancer, which since has been his focus of research. Michael has published 285 peer reviewed papers with a H-Index of 53. For several years, Michael has become increasingly involved in organisational work and is currently chairing the Danish Urological Society and the Danish Prostate Group, as well as the Association of the Danish Multidisciplinary Cancer Groups and the Danish Prostrate Cancer Register.
Gedske Daugaard, MD, PhD
Professor of oncology at Rigshospitalet in Copenhagen, affiliated with the Department of Oncology under the Center for Cancer and Organ Diseases. Her research primarily focuses on uro-oncology.
Gedske Daugaard has been national principal investigator on several trials in disseminated prostate cancer and is former head of the clinical trial unit at Department of Oncology at Rigshospitalet. She also has extensive research experience in testicular cancer.
She has published 338 scientific articles and has been cited over 15,000 times in academic publications.
Registration for the Study Tour 2025
Send an email to contact@gesundheittravel.com if you wish to hear about other Study Tours.
From Stockholm
Early bird
- Flight
- Hotel
- Transport to and from venue
- 2-day program, including lunch
- Networking Dinner
Early bird Price before July 1:
SEK 6.000
Price After July 1:
SEK 7.040
From Copenhagen
Early bird
- Flight
- Hotel
- Transport to and from venue
- 2-day program, including lunch
- Networking Dinner
Early bird Price before July 1:
DKK 4.200
PRICE AFTER July 1:
DKK 5.000
From Helsinki
Early bird
- Flight
- Hotel
- Transport to and from venue
- 2-day program, including lunch
- Networking Dinner
Early bird Price before July 1:
EUR 725
PRICE AFter July 1:
EUR 855
From Oslo
Early bird
- Flight
- Hotel
- Transport to and from venue
- 2-day program, including lunch
- Networking Dinner
Early bird Price before July 1:
NOK 6.500
PRICE AFter July 1:
NOK 7.600
Do you want to learn from the best?
Are you a Nordic physician looking for opportunities to learn from the best specialists?
See what else Gesundheit Medical Travel can offer.
Our sponsors
This Study Tour is sponsored by a select number of life science companies whose contribution keeps the journey price low.
Gold sponsors
Silver sponsors
Bronze sponsors
Tel: +45 7070 2675
E-mail: CONTACT@GESUNDHEITTRAVEL.COM
GESUNDHEIT MEDICAL TRAVEL APS
Flaesketorvet 68
DK-1711 Copenhagen